207 related articles for article (PubMed ID: 17546593)
1. Mutations of the PIK3CA gene in hereditary colorectal cancers.
Miyaki M; Iijima T; Yamaguchi T; Takahashi K; Matsumoto H; Yasutome M; Funata N; Mori T
Int J Cancer; 2007 Oct; 121(7):1627-30. PubMed ID: 17546593
[TBL] [Abstract][Full Text] [Related]
2. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
[TBL] [Abstract][Full Text] [Related]
3. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
4. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
[TBL] [Abstract][Full Text] [Related]
5. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
[TBL] [Abstract][Full Text] [Related]
7. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
8. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Gallinger S; Vivona AA; Odze RD; Mitri A; O'Beirne CP; Berk TC; Bapat BV
Oncogene; 1995 May; 10(9):1875-8. PubMed ID: 7753564
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
10. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
Miyaki M; Iijima T; Konishi M; Sakai K; Ishii A; Yasuno M; Hishima T; Koike M; Shitara N; Iwama T; Utsunomiya J; Kuroki T; Mori T
Oncogene; 1999 May; 18(20):3098-103. PubMed ID: 10340381
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors.
Miyaki M; Yamaguchi T; Iijima T; Takahashi K; Matsumoto H; Mori T
Oncology; 2009; 76(6):430-4. PubMed ID: 19420964
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.
Lu SL; Akiyama Y; Nagasaki H; Saitoh K; Yuasa Y
Biochem Biophys Res Commun; 1995 Nov; 216(2):452-7. PubMed ID: 7488133
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
15. Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis.
Campbell F; Geraghty JM; Appleton MA; Williams ED; Williams GT
Hum Pathol; 1998 Dec; 29(12):1531-5. PubMed ID: 9865843
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
Wynter CV; Kambara T; Walsh MD; Leggett BA; Young J; Jass JR
Int J Cancer; 2006 Feb; 118(4):907-15. PubMed ID: 16152625
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
[TBL] [Abstract][Full Text] [Related]
19. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Soravia C; Bapat B; Cohen Z
Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
[TBL] [Abstract][Full Text] [Related]
20. Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors.
Yamaguchi T; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Nakayama Y; Mori T; Horiguchi S; Miyaki M
Oncology; 2014; 87(1):58-66. PubMed ID: 24994098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
